{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:04:00Z","timestamp":1792623840634,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":586,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/mt.2015.7","type":"journal-article","created":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T12:14:23Z","timestamp":1421410463000},"page":"488-500","source":"Crossref","is-referenced-by-count":42,"title":["Targeted Gene Delivery to the Enteric Nervous System Using AAV: A Comparison Across Serotypes and Capsid Mutants"],"prefix":"10.1016","volume":"23","author":[{"given":"Matthew J","family":"Benskey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan C","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J","family":"Galligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon E","family":"Boye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W","family":"Hauswirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanford L","family":"Boye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredric P","family":"Manfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.7_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene therapy using adeno-associated virus vectors","volume":"21","author":"Daya","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1038\/mt.2015.7_bib2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.gt.3302233","article-title":"Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors","volume":"11","author":"Flotte","year":"2004","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.7_bib3","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/gt.2008.68","article-title":"Clinical gene therapy using recombinant adeno-associated virus vectors","volume":"15","author":"Mueller","year":"2008","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.7_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1038\/mt.2015.7_bib5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/2625","article-title":"Peroral gene therapy of lactose intolerance using an adeno-associated virus vector","volume":"4","author":"During","year":"1998","journal-title":"Nat Med"},{"key":"10.1038\/mt.2015.7_bib6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/mt.2011.34","article-title":"Correction of neurological disease of mucopolysaccharidosis IIIB in adult mice by rAAV9 trans-blood-brain barrier gene delivery","volume":"19","author":"Fu","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.7_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fnmol.2014.00081","article-title":"Intravenous AAV9 efficiently transduces myenteric neurons in neonate and juvenile mice","volume":"7","author":"Gombash","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.1038\/mt.2015.7_bib8","series-title":"Enteric Nervous System (The-Brain-In-The-Gut)","author":"Wood","year":"2011"},{"key":"10.1038\/mt.2015.7_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/01.mpg.0000218696.58487.5b","article-title":"Enteric nervous system disease and recovery, plasticity, and regeneration","volume":"42","author":"Belkind-Gerson","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1038\/mt.2015.7_bib10","doi-asserted-by":"crossref","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.7_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1038\/mt.2015.7_bib12","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.25020","article-title":"Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov Disord"},{"key":"10.1038\/mt.2015.7_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/mds.23838","article-title":"Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov Disord"},{"key":"10.1038\/mt.2015.7_bib14","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1053\/gast.2002.33584","article-title":"Evolving pathophysiologic models of functional gastrointestinal disorders","volume":"122","author":"Mayer","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1038\/mt.2015.7_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson's disease","volume":"66","author":"Dawson","year":"2010","journal-title":"Neuron"},{"key":"10.1038\/mt.2015.7_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3233\/JPD-012138","article-title":"Loss of functional alpha-synuclein: a toxic event in Parkinson's disease?","volume":"2","author":"Kanaan","year":"2012","journal-title":"J Parkinsons Dis"},{"key":"10.1038\/mt.2015.7_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10048-007-0079-z","article-title":"Whole genome expression analyses of single- and double-knock-out mice implicate partially overlapping functions of alpha- and gamma-synuclein","volume":"8","author":"Kuhn","year":"2007","journal-title":"Neurogenetics"},{"key":"10.1038\/mt.2015.7_bib18","doi-asserted-by":"crossref","first-page":"e62097","DOI":"10.1371\/journal.pone.0062097","article-title":"Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors","volume":"8","author":"Kay","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.7_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/mt.2008.269","article-title":"High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors","volume":"17","author":"Petrs-Silva","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.7_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/mt.2010.234","article-title":"Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina","volume":"19","author":"Petrs-Silva","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.7_bib21","doi-asserted-by":"crossref","first-page":"59142","DOI":"10.1371\/journal.pone.0059142","article-title":"Small, N-terminal tags activate Parkin E3 ubiquitin ligase activity by disrupting its autoinhibited conformation","volume":"8","author":"Aslanidi","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.7_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1089\/hgtb.2012.194","article-title":"Bioengineering of AAV2 capsid at specific serine, threonine, or lysine residues improves its transduction efficiency in vitro and in vivo","volume":"24","author":"Gabriel","year":"2013","journal-title":"Hum Gene Ther Methods"},{"key":"10.1038\/mt.2015.7_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","article-title":"Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system","volume":"10","author":"Burger","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.7_bib24","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/sj.mt.6300227","article-title":"Time course of transgene expression after intrastriatal pseudotyped rAAV2\/1, rAAV2\/2, rAAV2\/5, and rAAV2\/8 transduction in the rat","volume":"15","author":"Reimsnider","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.7_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","article-title":"Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8","volume":"14","author":"Inagaki","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.7_bib26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.7_bib27","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.STR.32.5.1208","article-title":"Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain","volume":"32","author":"Ito","year":"2001","journal-title":"Stroke"},{"key":"10.1038\/mt.2015.7_bib28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"10.1038\/mt.2015.7_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0301-0082(98)00069-0","article-title":"Reactive microgliosis","volume":"57","author":"Streit","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1038\/mt.2015.7_bib30","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1126\/science.287.5457.1453","article-title":"An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy","volume":"287","author":"During","year":"2000","journal-title":"Science"},{"key":"10.1038\/mt.2015.7_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/mt.2009.15","article-title":"AAV9: a potential blood-brain barrier buster","volume":"17","author":"Manfredsson","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.7_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2015.7_bib33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1046-2023(02)00220-7","article-title":"Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors","volume":"28","author":"Zolotukhin","year":"2002","journal-title":"Methods"},{"key":"10.1038\/mt.2015.7_bib34","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1128\/JVI.01288-06","article-title":"Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes","volume":"80","author":"Wu","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.7_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.expneurol.2007.06.019","article-title":"rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease","volume":"207","author":"Manfredsson","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2015.7_bib36","doi-asserted-by":"crossref","first-page":"e76310","DOI":"10.1371\/journal.pone.0076310","article-title":"Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain","volume":"8","author":"Aschauer","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.7_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1566523054065039","article-title":"Immune responses to adeno-associated virus vectors","volume":"5","author":"Zaiss","year":"2005","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2015.7_bib38","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ymthe.2006.03.005","article-title":"Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection","volume":"13","author":"Jacobson","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.7_bib39","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1365-2982.2010.01508.x","article-title":"Inhibitory neuromuscular transmission to ileal longitudinal muscle predominates in neonatal guinea pigs","volume":"22","author":"Patel","year":"2010","journal-title":"Neurogastroenterol Motil"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616300624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616300624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T01:53:11Z","timestamp":1598665991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616300624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1525001616300624"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.7","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}